IL-1β, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: Relevance to peritonitis in CAPD

Kidney International

Volumn 50, Issue 4, 1996, Pages 1337-1343

  Yung, Susan ^a   Coles, Gerald A ^a   Davies, Malcolm ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY FAILURE; PERITONITIS; PRIORITY JOURNAL;

EID: 0029828628     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.446     Document Type: Article

References (48)

1. TOOLE BP: Hyaluronan and its binding proteins, the hyaladhedrins. Curr Opin Cell Biol 2:839-844, 1990
2. LAURENT TC: Biochemistry of hyaluronan. Acta Otolaryngol (Stockh) (Suppl) 442:7-24, 1987
3. LAURENT TC, FRASER JRE: Hyaluronan. FASEB J 6:2397-2404, 1992
4. GOENTINCK PF, STRIPE NS, TSONIS PA, CARLONE D: The tandemly repeated sequences of cartilage link protein contain the sites for interaction with hyaluronic acid. J Cell Biol 105:2403-2408, 1987
5. DELPECH B, HALAVENT C: Characterization and purification from human brain of a hyaluronic acid binding glycoprotein, hyaluronectin. J Neurochem 36:855-859, 1981
6. HARDINGHAM TE, MUIR H: The specific interactions of hyaluronic acid with cartilage proteoelycans. Biochim Biophys Acta 279:401-405, 1972
7. LEBARON RG, ZIMMERMANN DR, RUOSLAHTI E: Hyaluronate binding properties of versican. J Biol Chem 276:10003-10010, 1992
8. THOMAS GJ, BAYLISS MT, HARPER K, MASON RM, DAVIES M: Glomerular mesangial cells in vitro synthesize an aggregating proteoglycan immunologically related to versican, Biochem J 302:49-56, 1994
9. UNDERHILL CB: CD 44: The hyaluronan receptor. J Cell Sci 103:293-299, 1992
10. HARDWICK C, HOARE K, OWENS R, HOHN HP, HOOK M, MOORE D, CRIPPS V, AUSTLN L, NANCE DM, TURLEY EA: Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 117:1343-1350, 1992
11. YUNG S, COLES GA, WILLIAMS JD, DAVIES M: The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 46:527-533, 1994
12. HAMURA Y, ITO A, OKADA Y, MORI Y: Hyaluronic acid metabolism in inflamed mesenterium of guinea pig. Res Commun Chem Pathol Pharmacol 66:311-327, 1989
13. ELIAS JA, KROL RC, FREUNDLICH B, SAMPSON PM: Regulation of human fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin. J Clin Invest 81:325-333, 1988
14. HELDIN P, LAURENT TC, HELDIN CH: Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 258: 919-922, 1989
15. HELDIN P, ASPLUND T, YTTERBERG D, THELIN S, LAURENT TC: Characterization of the molecular mechanism involved in the activation of hyaluronan synthetase by platelet-derived growth factor in human mesothelial cells. Biochem J 283:165-170, 1992
16. SUZUKI M, ASPLIND T, YAMASHITA H, HELDIN C-H, HELDIN P: Stimualtion of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-β1 involves activation of protein kinase C. Bichem J 307:817-821, 1995
17. STYLIANOU E, JENNER LA, DAVIES M, COLES GA, WILLIAMS JD: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37:1563-1570, 1990
18. FORSANG AJ, HEY NJ, CARNEY SL, HARDINGHAM TE: An ELISA plate assay for hyaluronan using biotinylated proteoglycan G1 domain (HA-binding region). Matrix 10:305-313, 1990
19. BRAUNER A, HYLANDER B, WRETLIND B: Tumor necrosis factor-α, and interleukin-1β receptor anatonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 27:402-408, 1996
20. PHILIPSON LH, SCHWARTZ NB: Subcellular localization of hyaluronate synthesis in oligodcndroglioma cells. J Biol Chem 259:5017-5063, 1984
21. PREHM P: Hyaluronate is sythesised at plasma membranes. Biochem J 211220:181-18597-600, 1984
22. PREHM P: Synthesis of hyaluronate in differentiated teratocarcinoma cells. Biochem J 211:181-189, 1983
23. NOBLE PW, LAKE FR, HENSON PM, RICHES DW: Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by tumor necrosis factor-alpha-dependent mechanism in murine macro-phages. J Clin Invest 91:2368-2377, 1993
24. HAUBECK H-D, KOCK R, FISCHER D-C, GREILING H: Transforming growth factor β1, a major stimulator of hyaluronan synthesis in human synovial lining cells. Arthitis Rheum 38:669-677, 1995
25. ITO A, SHIMADA M, MORI Y: Regulation of hyaluronate production by interleukin-1 in human chorionic cells. Biochem Biophys Acta 1158: 91-97, 1993
26. KOKIA E, HURWITZ A, BEN-SHILOMO I, ADASHI EY, YANAGISHITA M: Receptor-mediated stimulatory effect of IL-1βon hyaluronic acid and proteoglycan biosynthesis by cultured rat ovarian cells: Role for heterologous cell-cell interactions. Endocrinology 133:2391-2394, 1993
27. KOTTINEN YT, SAARI H, NORDSTROM DC: Effect of interleukin-1 on hyaluronate synthesis by synovial fibroblastic cells. Clin Rheum 10: 151-154, 1991
28. BREBOROWICZ A, MARTIS L, OREOPOULOS DG: Properties of the peritoneal dialysate effluent and its effect on function of human mesothelial peritoneal cells, (abstract). J Am Soc Nephrol 6:522, 1995
29. KLEWES L, PREHM P: Intracellular signal transduction for serum activation of the hyaluronan synthase in eukaryotic cell lines. J Cell Physiol 160:539-544, 1994
30. DINARELLO CA: Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652, 1991
31. MOUTABARRIK A, NAKANISHI I, NAMIKI M, TSUBAKIHARA Y: Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients. Clin Nephrol 43:243-248, 1994
32. LANFRANCONE L, BORASCHI D, GHIARA P, FALINI B, GRIGNANI F, PERI G, MANTOVANI A, PELICCI PG: Human peritoneal mesothelial cells produce many cytokines (Granulocyte colony-stimulating factor [CSF], Granulocyte-monocyte-CSF, macrophage-CSF. interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1. Blood 80:2835-2842, 1992
33. DOUVDEVANI A, RAPOPORT J, KONFORTI A, ZLOTNIK M, CHAIMOVITZ C: The effect of peritoneal dialysis fluid on the release of IL-1β and TNFα by monocytes/macrophages. Perit Dial Int 13:112-117, 1993
34. TOPLEY N, MACKENZIE R, JORRES A, COLES GA, DAVIES M, WILLIAMS JD: Cytokine networks in CAPD. Interaction of resident cells during inflammation in the peritoneal cavity. Perit Dial Int 13:1-4, 1993
35. ZEMEL D, KOOMEN GCM, HART M, TEN BERGE RJM, STRUIJK DG, KREDIET RT: Relationship of TNFα, interleukin-6. and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Invest 122:686-696, 1994
36. ZEMEL D, KREDIET RT, KOOMEN GCM, KORTEKAAS WMR, GEERTZEN HGM, TEN BERGE RJM: Interleukin-8 during peritonitis in patients treated with CAPD: An in vivo model of acute inflammation. Nephrol Dial Transplant 9:169-174, 1994
37. ZEMEL D, IMHOLZ ALT, DE WAART DR, DINKLA C, STRUIJK DG, KREDIET RT: Appearance of tumor necrosis factor-α and soluble TNF-receptor I and II in peritoneal fluid of CAPD. Kidney Int 46:1422-1430, 1994
38. GOLDSTEIN CS, BOMALSKI JS, ZURIER RB, NELSON EG, DOUGLAS SD: Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int 26:733-740, 1984
39. DAVIES SJ, SUASSUNA J, OGG CS, CAMERON JS: Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. Kidney Int 36:661-668, 1989
40. BOS EN, VAN BRONSWIJK H, HELMERHORST TJM, OE LP, HOFFSMIT ECM, BEELEN RHJ: Distinct populations of elicited human macro-phages in peritoneal dialysis patients and women undergoing laparoscopy: A study of peroxidatic activity. J Leukocyte Biol 43:172-178, 1988
41. QIAO R-L, WANG H-S, YAN W, ODEKON LE, VECC-HIO DPJ, SMITH TJ, MALIK AB: Extracellular matrix hyaluronan is a determinant of the endothelial barrier. Am J Physiol 269:C103-C109, 1995
42. GOTLOIB L, SHOSTACK A, JAICHENKO J: Ruthenium-red-stained anionic charges of rat and mice mesothelial cells and basal lamina: The peritoneum is a negatively charged dialyzing membrane. Nephron 48:65-70, 1988
43. CLARRIS BJ, FRASER JRE: On the pericellular zone of mammalian cells in vitro. Exp Cell Res 49:181-193, 1968
44. KNUDSON CB, TOOLE BP: Changes in the pericellular matrix during differentiation of limb bud mesoderm. Dev Biol 112:308-318, 1985
45. HELDIN P, PERTOFF H: Synthesis and assembly of the hyaluronancoating coats around normal human mesothelual cells. Exp Cell Res 208:422-429, 1993
46. FRASER JRE, CLARRIS BJ: On the reactions of human synovial cells exposed to homologous leucocytes in vitro. Clin Exp Immunol 6:211-225, 1970
47. MCBRIDE WH, BARD JBL: Hyaluronidase-sensitive halo's around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J Exp Med 49:507-515, 1979
48. GOTLEIB L, SHUSTAK A, JAICHENKO J: Loss of mesothelial electronegative fixed charges during murine septic peritonitis. Nephron 51:77-83, 1989